Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+-ATPase inhibitors and other xenobiotics
- 1 January 2003
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 33 (2) , 107-118
- https://doi.org/10.1080/0049825021000023978
Abstract
1. Xenobiotic-mediated regulation of mRNA expression of all members of the human cytochrome P450 (CYP) 1 family has been measured by RT-PCR in the hepatoma cell line, HepG2. Besides the positive control β-naphthoflavone, the H + /K + -ATPase inhibitors omeprazole, lansoprazole, pantoprazole and rabeprazole and the anti-malaria drug primaquine were included in this study. 2. β-Naphthoflavone, primaquine, omeprazole and lansoprazole increased mRNA levels of CYP1A1, CYP1A2 and CYP1B1. Induction by rabeprazole was significant only for CYP1A1 and CYP1A2, whereas none of the CYP1 mRNAs was induced by pantoprazole. This result was confirmed in primary human hepatocytes. 3. Transcriptional regulation was proved by inhibition of induction with actinomycin D. 4. Increase of CYP1 mRNA was significant after 1 h and maximal after 4 h. CYP1B1, but not CYP1A1 or CYP1A2, was dramatically down-regulated between 4 and 24 h. This decrease was prevented by treatment of cells with actinomycin D after induction, indicating an active transcription-dependent mechanism of CYP1B1 mRNA degradation. 5. In conclusion, xenobiotics inducing CYP1A1 mRNA expression have been shown also to induce CYP1A2 and CYP1B1, differing only with regard to level and time course of induction.Keywords
This publication has 19 references indexed in Scilit:
- The Human Cytochrome P450 1A1 mRNA Is Rapidly Degraded In HepG2 CellsArchives of Biochemistry and Biophysics, 2000
- Induction of Cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but Not of CYP2C9, CYP2C19, Multidrug Resistance (MDR-1) and Multidrug Resistance Associated Protein (MRP-1) by Prototypical Inducers in Human HepatocytesBiochemical and Biophysical Research Communications, 2000
- INDUCTION OF CYP1A BY VARIOUS BENZIMIDAZOLES AND ITS SIGNIFICANCE IN ADMINISTRATIVE DRUG REGULATIONDrug Metabolism Reviews, 1999
- Prediction of Aryl Hydrocarbon Receptor-Mediated Enzyme Induction of Drugs and Chemicals by mRNA QuantificationChemical Research in Toxicology, 1998
- Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cellsCarcinogenesis: Integrative Cancer Research, 1997
- Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell lineXenobiotica, 1997
- The effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: Evidence for induction of a novel 17β-estradiol 4-hydroxylaseThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Specific and Dose–Dependent Enzyme Induction by Omeprazole in Human BeingsHepatology, 1994
- Response of Human CYP1-Luciferase Plasmids to 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Polycyclic Aromatic HydrocarbonsToxicology and Applied Pharmacology, 1993
- Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450Gastroenterology, 1990